347 related articles for article (PubMed ID: 27677335)
1. Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity.
Ooi WF; Xing M; Xu C; Yao X; Ramlee MK; Lim MC; Cao F; Lim K; Babu D; Poon LF; Lin Suling J; Qamra A; Irwanto A; Qu Zhengzhong J; Nandi T; Lee-Lim AP; Chan YS; Tay ST; Lee MH; Davies JO; Wong WK; Soo KC; Chan WH; Ong HS; Chow P; Wong CY; Rha SY; Liu J; Hillmer AM; Hughes JR; Rozen S; Teh BT; Fullwood MJ; Li S; Tan P
Nat Commun; 2016 Sep; 7():12983. PubMed ID: 27677335
[TBL] [Abstract][Full Text] [Related]
2. Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancer.
Sheng T; Ho SWT; Ooi WF; Xu C; Xing M; Padmanabhan N; Huang KK; Ma L; Ray M; Guo YA; Sim NL; Anene-Nzelu CG; Chang MM; Razavi-Mohseni M; Beer MA; Foo RSY; Sundar R; Chan YH; Tan ALK; Ong X; Skanderup AJ; White KP; Jha S; Tan P
Genome Med; 2021 Oct; 13(1):158. PubMed ID: 34635154
[TBL] [Abstract][Full Text] [Related]
3. Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilities.
Ho SWT; Sheng T; Xing M; Ooi WF; Xu C; Sundar R; Huang KK; Li Z; Kumar V; Ramnarayanan K; Zhu F; Srivastava S; Isa ZFBA; Anene-Nzelu CG; Razavi-Mohseni M; Shigaki D; Ma H; Tan ALK; Ong X; Lee MH; Tay ST; Guo YA; Huang W; Li S; Beer MA; Foo RSY; Teh M; Skanderup AJ; Teh BT; Tan P
Gut; 2023 Feb; 72(2):226-241. PubMed ID: 35817555
[TBL] [Abstract][Full Text] [Related]
4. Integrated paired-end enhancer profiling and whole-genome sequencing reveals recurrent
Ooi WF; Nargund AM; Lim KJ; Zhang S; Xing M; Mandoli A; Lim JQ; Ho SWT; Guo Y; Yao X; Lin SJ; Nandi T; Xu C; Ong X; Lee M; Tan AL; Lam YN; Teo JX; Kaneda A; White KP; Lim WK; Rozen SG; Teh BT; Li S; Skanderup AJ; Tan P
Gut; 2020 Jun; 69(6):1039-1052. PubMed ID: 31542774
[TBL] [Abstract][Full Text] [Related]
5. MEK inhibition remodels the active chromatin landscape and induces SOX10 genomic recruitment in BRAF(V600E) mutant melanoma cells.
Fufa TD; Baxter LL; Wedel JC; Gildea DE; ; Loftus SK; Pavan WJ
Epigenetics Chromatin; 2019 Aug; 12(1):50. PubMed ID: 31399133
[TBL] [Abstract][Full Text] [Related]
6. Super-enhancers are transcriptionally more active and cell type-specific than stretch enhancers.
Khan A; Mathelier A; Zhang X
Epigenetics; 2018; 13(9):910-922. PubMed ID: 30169995
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic super-enhancers in cancer: mechanisms and therapeutic targets.
Bacabac M; Xu W
Cancer Metastasis Rev; 2023 Jun; 42(2):471-480. PubMed ID: 37059907
[TBL] [Abstract][Full Text] [Related]
8. The hyper-activation of transcriptional enhancers in breast cancer.
Li QL; Wang DY; Ju LG; Yao J; Gao C; Lei PJ; Li LY; Zhao XL; Wu M
Clin Epigenetics; 2019 Mar; 11(1):48. PubMed ID: 30867030
[TBL] [Abstract][Full Text] [Related]
9. Chromatin interaction networks revealed unique connectivity patterns of broad H3K4me3 domains and super enhancers in 3D chromatin.
Thibodeau A; Márquez EJ; Shin DG; Vera-Licona P; Ucar D
Sci Rep; 2017 Oct; 7(1):14466. PubMed ID: 29089515
[TBL] [Abstract][Full Text] [Related]
10. Contribution of transposable elements and distal enhancers to evolution of human-specific features of interphase chromatin architecture in embryonic stem cells.
Glinsky GV
Chromosome Res; 2018 Mar; 26(1-2):61-84. PubMed ID: 29335803
[TBL] [Abstract][Full Text] [Related]
11. Integrative functional analysis of super enhancer SNPs for coronary artery disease.
Gong J; Qiu C; Huang D; Zhang Y; Yu S; Zeng C
J Hum Genet; 2018 May; 63(5):627-638. PubMed ID: 29491472
[TBL] [Abstract][Full Text] [Related]
12. The molecular understanding of super-enhancer dysregulation in cancer.
Yoshino S; Suzuki HI
Nagoya J Med Sci; 2022 May; 84(2):216-229. PubMed ID: 35967935
[TBL] [Abstract][Full Text] [Related]
13. Metabolic reprogramming directed by super-enhancers in tumors: An emerging landscape.
Zhou Z; Li J; Ousmane D; Peng L; Yuan X; Wang J
Mol Ther; 2024 Mar; 32(3):572-579. PubMed ID: 38327048
[TBL] [Abstract][Full Text] [Related]
14. Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming.
Xiong L; Wu F; Wu Q; Xu L; Cheung OK; Kang W; Mok MT; Szeto LLM; Lun CY; Lung RW; Zhang J; Yu KH; Lee SD; Huang G; Wang CM; Liu J; Yu Z; Yu DY; Chou JL; Huang WH; Feng B; Cheung YS; Lai PB; Tan P; Wong N; Chan MW; Huang TH; Yip KY; Cheng AS; To KF
Nat Commun; 2019 Jan; 10(1):335. PubMed ID: 30659195
[TBL] [Abstract][Full Text] [Related]
15. Mapping the evolving landscape of super-enhancers during cell differentiation.
Kai Y; Li BE; Zhu M; Li GY; Chen F; Han Y; Cha HJ; Orkin SH; Cai W; Huang J; Yuan GC
Genome Biol; 2021 Sep; 22(1):269. PubMed ID: 34526084
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide chromatin interaction profiling reveals a vital role of super-enhancers and rearrangements in host enhancer contacts during BmNPV infection.
Zhao S; Li Y; Chen G; Wang X; Chen N; Wu X
Genome Res; 2023 Oct; 33(11):1958-74. PubMed ID: 37871969
[TBL] [Abstract][Full Text] [Related]
17. Etiology of super-enhancer reprogramming and activation in cancer.
Zhou RW; Parsons RE
Epigenetics Chromatin; 2023 Jul; 16(1):29. PubMed ID: 37415185
[TBL] [Abstract][Full Text] [Related]
18. Epigenomic Promoter Alterations Amplify Gene Isoform and Immunogenic Diversity in Gastric Adenocarcinoma.
Qamra A; Xing M; Padmanabhan N; Kwok JJT; Zhang S; Xu C; Leong YS; Lee Lim AP; Tang Q; Ooi WF; Suling Lin J; Nandi T; Yao X; Ong X; Lee M; Tay ST; Keng ATL; Gondo Santoso E; Ng CCY; Ng A; Jusakul A; Smoot D; Ashktorab H; Rha SY; Yeoh KG; Peng Yong W; Chow PKH; Chan WH; Ong HS; Soo KC; Kim KM; Wong WK; Rozen SG; Teh BT; Kappei D; Lee J; Connolly J; Tan P
Cancer Discov; 2017 Jun; 7(6):630-651. PubMed ID: 28320776
[TBL] [Abstract][Full Text] [Related]
19. Leveraging Tissue-Specific Enhancer-Target Gene Regulatory Networks Identifies Enhancer Somatic Mutations That Functionally Impact Lung Cancer.
Hariprakash JM; Salviato E; La Mastra F; Sebestyén E; Tagliaferri I; Silva RS; Lucini F; Farina L; Cinquanta M; Rancati I; Riboni M; Minardi SP; Roz L; Gorini F; Lanzuolo C; Casola S; Ferrari F
Cancer Res; 2024 Jan; 84(1):133-153. PubMed ID: 37855660
[TBL] [Abstract][Full Text] [Related]
20. Epigenomic analysis detects aberrant super-enhancer DNA methylation in human cancer.
Heyn H; Vidal E; Ferreira HJ; Vizoso M; Sayols S; Gomez A; Moran S; Boque-Sastre R; Guil S; Martinez-Cardus A; Lin CY; Royo R; Sanchez-Mut JV; Martinez R; Gut M; Torrents D; Orozco M; Gut I; Young RA; Esteller M
Genome Biol; 2016 Jan; 17():11. PubMed ID: 26813288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
